"1"^^ . "NT13186" . . "2"^^ . "The aim of the study is to determine in patients with established CHD (AMI and coronary revascularization) whether the recommendations on cardiovascular disease prevention are being followed and what level of control has been achieved. The methodology is derived from EURASPIRE I-III studies, the Czech Republic participated in all of them, it will be possible to compare recent results internationally as in time trends. Patients admitted for CHD event or revascularization procedure not less than 6 months and not more than 3 years prior to the date of interview will be identified. The data collection will be based on a review of patient medical records and a patient interview and examination. First degree blood relatives of those patients with premature disease will be screened by postal questionnaire. Longitudinal mortality data from EURASPIRE I-III will be analysed.Specific substudies aimed on further risk factors in secondary IHD prevention will be performed."@en . "2012-04-01+02:00"^^ . "secondary CHD prevention; CV disease prevention guidelin; EURASPIRE IV; new secondary CHD risk factors"@en . "2015-01-22+01:00"^^ . "P\u0159edm\u011Btem \u0159e\u0161en\u00ED je zjistit, jak jsou u pacient\u016F s potvrzenou ICHS (pacienti po prod\u011Blan\u00E9m AIM a/nebo po proveden\u00E9 katetriza\u010Dn\u00ED nebo chirurgick\u00E9 revaskularizaci myokardu) aktu\u00E1ln\u011B dodr\u017Eov\u00E1na doporu\u010Den\u00ED KV prevence a jak\u00E9 kontroly rizikov\u00FDch faktor\u016F je dosa\u017Eeno. Metodika vych\u00E1z\u00ED ze studi\u00ED EURASPIRE I-III (1995-1996, 1999-2000 a 2006-2007). V\u0161ech t\u011Bchto studi\u00ED se \u010CR z\u00FA\u010Dastnila, je mo\u017En\u00E9 mezin\u00E1rodn\u00ED i longitudin\u00E1ln\u00ED srovn\u00E1n\u00ED v\u00FDsledk\u016F/trend\u016F. Pacienti hospitalizovan\u00ED pro potvrzenou ICHS p\u0159ed 6i a v\u00EDce m\u011Bs\u00EDci v IKEM budou pozv\u00E1ni k ambulantn\u00EDmu vy\u0161et\u0159en\u00ED podle protokolu (vypln\u011Bn\u00ED dotazn\u00EDk\u016F, vy\u0161et\u0159en\u00ED l\u00E9ka\u0159em, laboratorn\u00ED n\u00E1b\u011Bry, instrument\u00E1ln\u00ED vy\u0161et\u0159en\u00ED). Budou analyzov\u00E1na hospitaliza\u010Dn\u00ED data a data z\u00EDskan\u00E1 ambulantn\u00EDm vy\u0161et\u0159en\u00EDm. Bude analyzov\u00E1na KV prevence u p\u0159\u00EDbuzn\u00FDch proband\u016F s p\u0159ed\u010Dasnou ICHS a longitudin\u00E1ln\u00ED mortalitn\u00ED data p\u0159edchoz\u00EDch studi\u00ED EURASPIRE. Provedeme studie n\u011Bkter\u00FDch parametr\u016F d\u00E1le stratifikuj\u00EDc\u00EDch riziko v sekund\u00E1rn\u00ED prevenci ICHS." . "http://www.isvav.cz/projectDetail.do?rowId=NT13186"^^ . . . "0"^^ . . . . "secondary CHD prevention" . "Coronary heart disease secondary prevention in selected sample of Czech population - Czech EURASPIRE IV Study."@en . "2014-12-31+01:00"^^ . "2013-03-26+01:00"^^ . . . . . "Sekund\u00E1rn\u00ED prevence ICHS ve vybran\u00E9m vzorku \u010Desk\u00E9 populace - \u010Desk\u00E1 \u010D\u00E1st studie EURASPIRE IV." . . . . " EURASPIRE IV" . . . . " CV disease prevention guidelin" . "2"^^ . . "2"^^ .